CLINICAL TRIALS PROFILE FOR ORUVAIL
✉ Email this page to a colleague
All Clinical Trials for ORUVAIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00688961 ↗ | Effects of Omacor and Aspirin on Platelet Function | Completed | Sanford Research | Early Phase 1 | 2007-06-01 | Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can affect blood clotting by altering the function of the blood platelets. Aspirin can do the same. The purpose of this study is to determine the individual and combined effects of these two agents on platelet function using a whole blood method. |
| NCT02099006 ↗ | Novel Topical Therapies for the Treatment of Genital Pain | Completed | Mae Stone Goode Foundation | Phase 2/Phase 3 | 2013-11-01 | This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning. |
| NCT02099006 ↗ | Novel Topical Therapies for the Treatment of Genital Pain | Completed | University of Rochester | Phase 2/Phase 3 | 2013-11-01 | This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ORUVAIL
Condition Name
Clinical Trial Locations for ORUVAIL
Trials by Country
Clinical Trial Progress for ORUVAIL
Clinical Trial Phase
Clinical Trial Sponsors for ORUVAIL
Sponsor Name
